Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 13, Issue 02, Pages 257
Publisher
Oxford University Press (OUP)
Online
2009-09-24
DOI
10.1017/s1461145709990654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia
- (2009) Ali Doruk et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia
- (2008) Fu-Ling Yan et al. ACTA NEUROPATHOLOGICA
- Effect of a short- and long-term treatment with Ginkgo biloba extract on Amyloid Precursor Protein Levels in a transgenic mouse model relevant to Alzheimer’s disease
- (2008) Sabine Augustin et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- β2-Microglobulin abnormalities in antipsychotic-naïve schizophrenia: Evidence for immune pathogenesis
- (2008) Seetharamaiah Chittiprol et al. BRAIN BEHAVIOR AND IMMUNITY
- Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis
- (2008) Venkata S. Kotakadi et al. CARCINOGENESIS
- Protective effects of Ginkgo biloba against rat liver carcinogenesis
- (2008) Marcos C. Dias et al. CHEMICO-BIOLOGICAL INTERACTIONS
- GuidAge Study: A 5-Year Double Blind, Randomised Trial of EGb 761 for the Prevention of Alzheimers Disease in Elderly Subjects with Memory Complaints. I. Rationale, Design and Baseline Data
- (2008) Sandrine Andrieu et al. Current Alzheimer Research
- EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress
- (2008) Patricia Rojas et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3and Serotonin 5-HT1Aand 5-HT2AReceptors: Design, Synthesis, and Effects on Behavior
- (2008) Stefania Butini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacy With Second-Generation Antipsychotics: A Review of Evidence
- (2008) Anand K. Pandurangi et al. Journal of Psychiatric Practice
- Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT2A serotonergic and α1 adrenergic antagonism
- (2008) Scott D. Philibin et al. PSYCHOPHARMACOLOGY
- Systemic Hypotheses for Generalized Cognitive Deficits in Schizophrenia: A New Take on An Old Problem
- (2008) D. Dickinson et al. SCHIZOPHRENIA BULLETIN
- Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia
- (2008) Ilaria Spoletini et al. SCHIZOPHRENIA RESEARCH
- Ginkgo Biloba Extract Neuroprotective Action Is Dependent on Heme Oxygenase 1 in Ischemic Reperfusion Brain Injury
- (2008) Sofiyan Saleem et al. STROKE
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
- (2008) Irving Kirsch et al. PLOS MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started